BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 31115492)

  • 1. NMDA receptor activation inhibits the protective effect of BM‑MSCs on bleomycin‑induced lung epithelial cell damage by inhibiting ERK signaling and the paracrine factor HGF.
    Peng X; Li X; Li C; Yue S; Huang Y; Huang P; Cheng H; Zhou Y; Tang Y; Liu W; Feng D; Luo Z
    Int J Mol Med; 2019 Jul; 44(1):227-239. PubMed ID: 31115492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NMDA receptor activation inhibits the antifibrotic effect of BM-MSCs on bleomycin-induced pulmonary fibrosis.
    Li X; Li C; Tang Y; Huang Y; Cheng Q; Huang X; Zhao F; Hao C; Feng D; Xu J; Han J; Tang S; Liu W; Yue S; Luo Z
    Am J Physiol Lung Cell Mol Physiol; 2018 Sep; 315(3):L404-L421. PubMed ID: 29722562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paracrine factors from mesenchymal stem cells attenuate epithelial injury and lung fibrosis.
    Shen Q; Chen B; Xiao Z; Zhao L; Xu X; Wan X; Jin M; Dai J; Dai H
    Mol Med Rep; 2015 Apr; 11(4):2831-7. PubMed ID: 25514921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocyte Growth Factor Is Required for Mesenchymal Stromal Cell Protection Against Bleomycin-Induced Pulmonary Fibrosis.
    Cahill EF; Kennelly H; Carty F; Mahon BP; English K
    Stem Cells Transl Med; 2016 Oct; 5(10):1307-1318. PubMed ID: 27388243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulforaphane prevents bleomycin‑induced pulmonary fibrosis in mice by inhibiting oxidative stress via nuclear factor erythroid 2‑related factor‑2 activation.
    Yan B; Ma Z; Shi S; Hu Y; Ma T; Rong G; Yang J
    Mol Med Rep; 2017 Jun; 15(6):4005-4014. PubMed ID: 28487960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene transfer of hepatocyte growth factor by electroporation reduces bleomycin-induced lung fibrosis.
    Gazdhar A; Fachinger P; van Leer C; Pierog J; Gugger M; Friis R; Schmid RA; Geiser T
    Am J Physiol Lung Cell Mol Physiol; 2007 Feb; 292(2):L529-36. PubMed ID: 17056705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imbalance in the pro-hepatocyte growth factor activation system in bleomycin-induced lung fibrosis in mice.
    Phin S; Marchand-Adam S; Fabre A; Marchal-Somme J; Bantsimba-Malanda C; Kataoka H; Soler P; Crestani B
    Am J Respir Cell Mol Biol; 2010 Mar; 42(3):286-93. PubMed ID: 19448157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β-catenin induces A549 alveolar epithelial cell mesenchymal transition during pulmonary fibrosis.
    Song P; Zheng JX; Xu J; Liu JZ; Wu LY; Liu C
    Mol Med Rep; 2015 Apr; 11(4):2703-10. PubMed ID: 25435076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocyte growth factor inhibits epithelial to myofibroblast transition in lung cells via Smad7.
    Shukla MN; Rose JL; Ray R; Lathrop KL; Ray A; Ray P
    Am J Respir Cell Mol Biol; 2009 Jun; 40(6):643-53. PubMed ID: 18988920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amelioration of Endoplasmic Reticulum Stress by Mesenchymal Stem Cells via Hepatocyte Growth Factor/c-Met Signaling in Obesity-Associated Kidney Injury.
    Li B; Leung JCK; Chan LYY; Yiu WH; Li Y; Lok SWY; Liu WH; Chan KW; Tse HF; Lai KN; Tang SCW
    Stem Cells Transl Med; 2019 Sep; 8(9):898-910. PubMed ID: 31054183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microvesicles derived from human Wharton's Jelly mesenchymal stem cells ameliorate acute lung injury partly mediated by hepatocyte growth factor.
    Chen W; Wang S; Xiang H; Liu J; Zhang Y; Zhou S; Du T; Shan L
    Int J Biochem Cell Biol; 2019 Jul; 112():114-122. PubMed ID: 31100425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mTOR/STAT-3 pathway mediates mesenchymal stem cell-secreted hepatocyte growth factor protective effects against lipopolysaccharide-induced vascular endothelial barrier dysfunction and apoptosis.
    Meng SS; Guo FM; Zhang XW; Chang W; Peng F; Qiu HB; Yang Y
    J Cell Biochem; 2019 Mar; 120(3):3637-3650. PubMed ID: 30242894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal mitochondrial iron metabolism damages alveolar type II epithelial cells involved in bleomycin-induced pulmonary fibrosis.
    Shao M; Cheng H; Li X; Qiu Y; Zhang Y; Chang Y; Fu J; Shen M; Xu X; Feng D; Han Y; Yue S; Zhou Y; Luo Z
    Theranostics; 2024; 14(7):2687-2705. PubMed ID: 38773980
    [No Abstract]   [Full Text] [Related]  

  • 14. Emodin ameliorates bleomycin-induced pulmonary fibrosis in rats by suppressing epithelial-mesenchymal transition and fibroblast activation.
    Guan R; Wang X; Zhao X; Song N; Zhu J; Wang J; Wang J; Xia C; Chen Y; Zhu D; Shen L
    Sci Rep; 2016 Oct; 6():35696. PubMed ID: 27774992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncostatin M-Preconditioned Mesenchymal Stem Cells Alleviate Bleomycin-Induced Pulmonary Fibrosis Through Paracrine Effects of the Hepatocyte Growth Factor.
    Lan YW; Theng SM; Huang TT; Choo KB; Chen CM; Kuo HP; Chong KY
    Stem Cells Transl Med; 2017 Mar; 6(3):1006-1017. PubMed ID: 28297588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenylbutyric acid inhibits epithelial-mesenchymal transition during bleomycin-induced lung fibrosis.
    Zhao H; Qin HY; Cao LF; Chen YH; Tan ZX; Zhang C; Xu DX
    Toxicol Lett; 2015 Jan; 232(1):213-20. PubMed ID: 25455454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isorhamnetin protects against bleomycin-induced pulmonary fibrosis by inhibiting endoplasmic reticulum stress and epithelial-mesenchymal transition.
    Zheng Q; Tong M; Ou B; Liu C; Hu C; Yang Y
    Int J Mol Med; 2019 Jan; 43(1):117-126. PubMed ID: 30387812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HGF reduces advancing lung fibrosis in mice: a potential role for MMP-dependent myofibroblast apoptosis.
    Mizuno S; Matsumoto K; Li MY; Nakamura T
    FASEB J; 2005 Apr; 19(6):580-2. PubMed ID: 15665032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocyte growth factor secreted by bone marrow stem cell reduce ER stress and improves repair in alveolar epithelial II cells.
    Nita I; Hostettler K; Tamo L; Medová M; Bombaci G; Zhong J; Allam R; Zimmer Y; Roth M; Geiser T; Gazdhar A
    Sci Rep; 2017 Feb; 7():41901. PubMed ID: 28157203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility of microtubule
    Kesireddy VS; Chillappagari S; Ahuja S; Knudsen L; Henneke I; Graumann J; Meiners S; Ochs M; Ruppert C; Korfei M; Seeger W; Mahavadi P
    FASEB J; 2019 Nov; 33(11):12392-12408. PubMed ID: 31431059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.